Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia A Mattingly

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Pharmacology|June 16, 2004
The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cellsAimee K Bence, Cynthia A Mattingly, Thomas G Burke, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2008
Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimizationXiaowei Dong, Cynthia A Mattingly, Michael Tseng, et al.
Cancer Research|April 23, 2009
Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATPXiaowei Dong, Cynthia A Mattingly, Michael T Tseng, et al.
Anticancer Research|August 5, 2010
Anticancer activity of novel unnatural synthetic isoprenoidsVal R Adams, David L Deremer, Bojana Stevich, et al.
Cancer|July 23, 2013
Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration ProgramLaura C Seeff, Janet Royalty, William E Helsel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|June 16, 2004
The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cellsAimee K Bence, Cynthia A Mattingly, Thomas G Burke, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2008
Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimizationXiaowei Dong, Cynthia A Mattingly, Michael Tseng, et al.
Cancer Research|April 23, 2009
Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATPXiaowei Dong, Cynthia A Mattingly, Michael T Tseng, et al.
Anticancer Research|August 5, 2010
Anticancer activity of novel unnatural synthetic isoprenoidsVal R Adams, David L Deremer, Bojana Stevich, et al.
Cancer|July 23, 2013
Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration ProgramLaura C Seeff, Janet Royalty, William E Helsel, et al.
Pageof 1